Literature DB >> 6689647

Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure.

M E Leithe, R D Margorien, J B Hermiller, D V Unverferth, C V Leier.   

Abstract

Central and regional (hepatic, renal, and limb) hemodynamic data are presented for a normal population (n = 16) and for a group of patients with congestive heart failure (n = 64). The patient population represented a wide spectrum of severity of congestive heart failure. Various relationships between central and regional hemodynamics were analyzed. The results indicate that in congestive heart failure blood flow to hepatic, renal, and limb regions is significantly decreased, and that this decrease is proportional and linearly related to the reduction in cardiac output. The vascular resistances of these regions correlated directly with systemic vascular resistance. Changes in renal vascular resistance and renal blood flow became attenuated as the severity of the heart failure advanced from moderate to severe and at higher levels of systemic vascular resistance. There was little to no correlation between systemic blood pressure and liver, kidney, and limb blood flow for the range of systemic pressures studied.

Entities:  

Mesh:

Year:  1984        PMID: 6689647     DOI: 10.1161/01.cir.69.1.57

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  36 in total

1.  Comment on: "A Physiologically Based Pharmacokinetic Drug-Disease Model to Predict Carvedilol Exposure in Adult and Paediatric Heart Failure Patients by Incorporating Pathophysiological Changes in Hepatic and Renal Blood".

Authors:  Guo-Fu Li; Xiao Gu; Guo Yu; Shui-Yu Zhao; Qing-Shan Zheng
Journal:  Clin Pharmacokinet       Date:  2016-01       Impact factor: 6.447

2.  Beta blocker treatment is associated with improvement in renal function and anaemia in patients with heart failure.

Authors:  W Khan; S M Deepak; T Coppinger; C Waywell; A Borg; L Harper; S G Williams; N H Brooks
Journal:  Heart       Date:  2006-12       Impact factor: 5.994

3.  Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure.

Authors:  A P Good; D V Unverferth; C V Leier
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

Review 4.  The kidney in heart failure: an update.

Authors:  Kevin Damman; Jeffrey M Testani
Journal:  Eur Heart J       Date:  2015-04-02       Impact factor: 29.983

Review 5.  The role of the kidney in acute and chronic heart failure.

Authors:  Gaetano Ruocco; Alberto Palazzuoli; Jozine M Ter Maaten
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

6.  Alkaline Phosphatase: A Biomarker of Cardiac Function in Pediatric Patients.

Authors:  Elizabeth S Makil; Xinyu Tang; Elizabeth A Frazier; R Thomas Collins
Journal:  Pediatr Cardiol       Date:  2017-02-09       Impact factor: 1.655

Review 7.  The influence of heart failure on the pharmacokinetics of cardiovascular and non-cardiovascular drugs: a critical appraisal of the evidence.

Authors:  Arduino A Mangoni; Elzbieta A Jarmuzewska
Journal:  Br J Clin Pharmacol       Date:  2018-10-14       Impact factor: 4.335

8.  Prognostic significance of dilated inferior vena cava in advanced decompensated heart failure.

Authors:  Hsin-Fu Lee; Lung-An Hsu; Chi-Jen Chang; Yi-Hsin Chan; Chun-Li Wang; Wan-Jing Ho; Pao-Hsien Chu
Journal:  Int J Cardiovasc Imaging       Date:  2014-06-18       Impact factor: 2.357

Review 9.  Clinical pharmacokinetics of ranolazine.

Authors:  Markus Jerling
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

10.  Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure.

Authors:  Stefanie Albers; Bernd Meibohm; Thomas S Mir; Stephanie Läer
Journal:  Br J Clin Pharmacol       Date:  2007-11-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.